NOMON Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; Representative Director: Kei Yamana; hereinafter, “NOMON”) has revised the price of the company’s first nutraceutical*1 product, which contains the ingredient NMN (nicotinamide mononucleotide) made in Japan, on May 13th, 2020.
NOMON has enhanced the production system for NMN to increase its production volume by over 10 times as compared to the previous year so as to provide this product to even more people to make “productive aging” a possibility for them on this occasion of the first anniversary of the launch of this product. As a result, NOMON can now offer the product at 58,000 yen (exclusive of tax), which is around 60% lower than before.
Currently, this product is primarily used by business managers and their families, people who are health and beauty-conscious, as well as top athletes. The price has been revised in the hope of making the product more accessible to an even wider range of people, including busy businesspersons.
Moving forward, NOMON will further strengthen the company’s production system to offer its products at prices that are affordable to even more people and fulfill their dream of achieving productive aging.
A generic term for food and beverages that have a scientific basis for the maintenance of general health and well-being.